Veracyte Stock Story
| VCYT Stock | USD 19.37 0.86 4.25% |
Slightly above 70% of Veracyte's investor base is looking to short. The analysis of the overall investor sentiment regarding Veracyte suggests that many traders are alarmed. Veracyte's investor sentiment overview provides quick insight into current market opportunities from investing in Veracyte. The current market sentiment, together with Veracyte's historical and current headlines, can help investors time the market. In addition, many technical investors use Veracyte stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Veracyte stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Veracyte daily returns and investor perception about the current price of Veracyte as well as its diversification or hedging effects on your existing portfolios.
Veracyte |
Requested story not found. it has been either deleted or moved. View all stories for Veracyte.
Veracyte Latest Timeline
Veracyte is listed for 19.37. About 98.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.45. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Veracyte recorded a loss per share of 1.02. The entity had not issued any dividends in recent years.Check out Veracyte Hype Analysis, Veracyte Correlation and Veracyte Performance. For more information on how to buy Veracyte Stock please use our How to Invest in Veracyte guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Complementary Tools for Veracyte Stock analysis
When running Veracyte's price analysis, check to measure Veracyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Veracyte is operating at the current time. Most of Veracyte's value examination focuses on studying past and present price action to predict the probability of Veracyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Veracyte's price. Additionally, you may evaluate how the addition of Veracyte to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Veracyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Veracyte. If investors know Veracyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Veracyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.02) | Revenue Per Share 4.97 | Quarterly Revenue Growth 0.223 | Return On Assets (0.01) | Return On Equity (0.07) |
The market value of Veracyte is measured differently than its book value, which is the value of Veracyte that is recorded on the company's balance sheet. Investors also form their own opinion of Veracyte's value that differs from its market value or its book value, called intrinsic value, which is Veracyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Veracyte's market value can be influenced by many factors that don't directly affect Veracyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Veracyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Veracyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Veracyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.